HCPLive

The latest edition of the Provider's Digest, HCPLive's monthly newsletter spotlighting regulatory decisions and pipeline news, is now live! In our October 2024 recap, we spotlight 25 pieces of pipeline news, including 13 FDA decisions and 12 announcements of other regulatory updates. Be sure to subscribe for a recap of the therapies, companies, and individuals moving the needle in healthcare during the past month, delivered on the first Saturday of each new month! #FDANews #Healthcare #Medicine

In an announcement by Dermavant Sciences, new clinical data was presented from the open-label, long-term extension study of ADORING 3 for tapinarof cream, 1% (Vtama) treatment of adults and children as young as 2 years with atopic dermatitis. The new findings were presented at the 2024 Fall Clinical Congress in Las Vegas, and investigator Linda Stein Gold, MD, discussed the findings with the HCPLive team: https://lnkd.in/exaY5zps #Eczema #ADORING #tapinarof 

Article of the Week: A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension. Learn more about the 10-year follow-up data from the landmark Teen-LABS study:

Watch our iPub® Clinical Perspectives in IBD: A JAK Inhibitor in Crohn’s Disease to hear Tauseef Ali, MD explore the design and outcomes of a JAK Inhibitor’s Phase 3 Crohn’s Disease Program, showing its efficacy across symptomatic and objective endpoints. bit.ly/3ZsrALz

🫀 New Video Series! 🫀 In this series, we spotlight the evolving recognition of the interplay beteeen chronic kidney disease and cardiovascular risk as well as the role of finerenone (Kerendia; Bayer) in management of CV risk among patients with type 2 diabetes and CKD, with perspective from Anuradha (Anu) Lala-Trindade (Lala), MD of Mount Sinai Health System, and Edgar Lerma, MD. https://lnkd.in/eKHFkScg

ICYMI: 12-month data from the APPEAR-C3G phase 3 trial was presented at the American Society of Nephrology's #KidneyWk, offering new insight into the effects of iptacopan (Fabhalta; Novartis) in patients with C3 glomerulopathy. Building on the previously reported 6-month data, these results indicate a statistically significant reduction in proteinuria and a favorable safety profile. According to study investigator Carla Nester, MD, of the University of Iowa, these findings represent "a pivotal advancement for C3G management,” as they provide data on longer-term treatment targeting the underlying disease mechanism via the alternative complement pathway. Learn more: https://lnkd.in/ePkFGwhD #Nephrology #Healthcare

Can AI enhance physician diagnostic accuracy? A recent study, led by Ethan G., MBBS, MS, from the Center for Biomedical Informatics Research at Stanford University School of Medicine, suggests more research is needed to determine the potential and limitations of AI in clinical practice. Large language models outperformed physicians in complex cases but did not significantly improve diagnostic accuracy or reasoning when used as aids alongside conventional resources. Read more: https://lnkd.in/e9y8n9yx #HealthcareAI #MedicalResearch

From #AAO2024: Quan Dong Nguyen, MD, MSc and Jia-Horung Hung, MD from Byers Eye Institute at Stanford, Stanford University School of Medicine, highlight key takeaways from Phase 2 Neptune trial evaluating brepocitinib (Priovant Therapeutics) for the treatment of active non-infectious uveitis. Watch the full interview here: https://lnkd.in/eXVHs-QA #Ophthalmology

#SponsoredArticle. As treatment and prevention options for HIV expand, adopting a holistic and personalized approach to care is essential. A new cloud-based assessment tool assists clinicians in uncovering hidden patient needs and preferences, facilitating deeper discussions on treatment satisfaction and quality of life for more comprehensive support. Read more. bit.ly/4hsEZdp

New #Lungcast! A trio of experts join American Lung Association for a check-in on the Lung Health Cohort Research Study: - Dr. Ravi Kalhan of Northwestern University - The Feinberg School of Medicine - Dr. George Washko of Harvard Medical School and Brigham and Women's Hospital - Dr. Amy Olson of Boehringer Ingelheim Watch here: https://lnkd.in/evEJYQmY